Ad: GenVec began a Phase I trial in 18 patients

When administered directly into a hepatic tumor, the cytosine deaminase gene expresses an enzyme that converts 5-fluorocytosine, an oral antifungal agent, into the chemotherapeutic 5-fluorouracil (5-FU). ...